By David Tuller, DrPH On Friday, I had an e-mail exchange with Sir Andrew Dillon, chief executive of the NICE Guidance Executive. The other seven Guidance Executive members are various directors within the NICE hierarchy, including the communications director. This group will make the final decision about whether to accept the provisional decision of a …
Trial by Error: My E-Mail Exchange With NICE Chief Executive Read More »
By David Tuller, DrPH On November 17, 2015, a few weeks after publication of my 15,000-word investigation of the PACE trial, I posted a blog about a talk Peter White gave to Swiss Re employees on the findings from his bogus study. Professor White, of course, was the lead PACE investigator and also served–and apparently …
Trial by Error: Retired PACE Investigator Peter White and Swiss Re Read More »
By David Tuller, DrPH This week, the Journal of Health Psychology published a special issue containing a raft of commentaries on the PACE trial. Most of them slammed the study for its many, many unacceptable flaws. Not surprisingly, Sir Simon Wessely’s lackeys at the Science Media Centre immediately posted three comments from experts lauding the …
Trial by Error: The Science Media Centre’s Desperate Efforts to Defend PACE Read More »
By David Tuller, DrPH The National Institute for Health and Care Excellence, the U.K. organization that develops clinical guidelines for medical conditions, has rejected my freedom-of-information request for the names of the experts involved in the reassessment of the guidance for the illness it calls CFS/ME. This isn’t surprising, since the agency also recently rejected …
By David Tuller, DrPH The Countess of Mar, a well-known advocate for ME/CFS patients in the House of Lords, has received a negative response to her request for the names of the experts involved in the review of the NICE guideline for CFS/ME. The ME Association has not yet received a response related to the …
Trial by Error: NICE Declines to Disclose Names of Experts Read More »
By David Tuller, DrPH This month, the U.K. organization currently assessing whether to update the clinical guidelines for the illness it calls CFS/ME is seeking input from stakeholders in the process. Unfortunately, that’s not good news, it’s bad news. Why? The National Institute for Health and Care Excellence, or NICE, is an independent body that …
Trial by Error: The NICE guidelines, and more on the CDC Read More »
